Validation of quantitative structure-activity relationship (QSAR) model for photosensitizer activity prediction

International Journal of Molecular Sciences

Volumn 12, Issue 12, 2011, Pages 8626-8644

  Frimayanti, Neni ^a   Yam, Mun Li ^b   Lee, Hong Boon ^b   Othman, Rozana ^a   Zain, Sharifuddin M ^a   Rahman, Noorsaadah Abd ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b CANCER RESEARCH INITIATIVES FOUNDATION   (Malaysia)

Author keywords

IC 50 Half maximal inhibitory concentration; Photodynamic therapy; Photosensitizer; Porphyrin; QSAR

Indexed keywords

CHLOROPHYLLONE A; G2 ACID METHYL (15' HYDROXYPURPURIN 7 LACTONE METHYL DIESTER); G2 DIMETHYL ESTER (15' HYDROXYPURPURIN 7 LACTONE METHYL DIESTER); HYDRODXY PHEOPHORBIDE A; HYDRODXY PHEOPHORBIDE B METHYL ESTER; METHOXY G2 METHYL ESTER; PHEOPHORBIDE; PHEOPHORBIDE A; PHOTOSENSITIZING AGENT; PORPHYRIN DERIVATIVE; PURPURIN 18; PURPURIN 18 METHYL ESTER; PYROPHEOPHORBIDE A; PYROPHEOPHORBIDE A METHYL ESTER; UNCLASSIFIED DRUG;

ARTICLE; CORRELATION COEFFICIENT; MATHEMATICAL MODEL; MULTIPLE LINEAR REGRESSION ANALYSIS; PHOTODYNAMIC THERAPY; PREDICTIVE VALUE; QUANTITATIVE STRUCTURE ACTIVITY RELATION; VALIDATION PROCESS; VALIDATION STUDY; ALGORITHM; CHEMISTRY;

ALGORITHMS; PHOTOSENSITIZING AGENTS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84055211824     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms12128626     Document Type: Article

References (32)

1. Gerard L.C.C., Halimah Y., Second Report of National Cancer Register, Cancer Incidence in Malaysia; National Cancer Registry: Kuala Lumpur, Malaysia, 2003.
2. Nyman, E.; Hynninen, P.H. Research advances in the use of tetrapyrrolic photosensitizers for photodynamic therapy. J. Photochem. Photobiol. B 2004, 73, 1-28.
3. Henderson, B.W.; Dougherty, T.J. How does photodynamic therapy works. J. Photochem. Photobiol. 1992, 55, 145-157.
4. Detty M.R., Gibson S.L., Wagner S.J., Current clinical and preclinical photosensitizers for use in photodynamic therapy. J. Med. Chem. 2004, 47, 3897-3915.
5. Dougherty, T.J. Photosensitizers: Therapy and detection of malignant tumours. J. Photochem. Photobiol. 1987, 45, 879-889.
6. Dougherty, T.J. Photodynamic therapy. J. Photochem. Photobiol. 1993, 58, 895-900.
7. Macdonald, I.D.T. Basic principles of photodynamic therapy. J. Porphyr. Phthalocya. 2001, 5, 105-129.
8. Bonnett, R. Chemical Aspects of Photodynamic Therapy; Gordon and Breach Science: Amsterdam, The Netherlands, 2000.
9. Allison, R.R.; Downie, G.H.; Cuenca, R.; Hu, X.H.; Child, C.J.; Sibata, C.H. Photosensitizers in clinical PDT. Photodiagnosis Photodyn. Ther. 2004, 1, 27-42.
10. Vanyur, R.; Heberger, K.; Kovesdi, I.; Jakus, J. Prediction of tumoricidal activity and accumulation of photosensitizers in photodynamic therapy using multiple linear regression and artificial neural networks. J. Photochem. Photobiol. 2002, 75, 471-478.
11. Boyle, R.W.; Dolphyn, D. Structure and biodistribution relationships of photodynamic sensitizers. J. Photochem. Photobiol. 1996, 64, 469-485.
12. Henderson, B.W.; Bellnier, D.A.; Greco, W.R.; Sharma, A.; Pandey, R.K.; Vanghan, L.A.; Weishaupt, K.R.; Dougherty, T.J. An in vivo quantitative structure-activity relationship for congeneric series of pyropheophorbide derivatives as photosensitizers for photodynamic therapy. Cancer Res. 1997, 57, 4000-4007.
13. Potter, W.R.; Henderson, B.W.; Bellnier, D.A.; Pandey, R.K.; Vanghan, L.A.; Weishaupt, K.R.; Douherty, T.J. Parabolic quantitative structure-activity and photodynamic therapy: Application of three compartment model with clearance to the in vivo quantitative structure-activity relationships of a congeneric series of pyropheoporbide derivatives used as photosensitizers for photodynamic therapy. J. Photochem. Photobiol. 1999, 70, 781-788.
14. Depnath, A.K.; Jiang, S.; Strick, N.; Lin, K.; Haberfield, P.; Neurath, A.R. Three-dimensional structure-activity analysis of a series of porphyrins derivatives with anti hiv-1 activity targeted to the v3 loop of the gp120 envelope glycoprotein of the human immunodeficiency virus type 1. J. Med. Chem. 1994, 37, 1099-1108.
15. Golbraikh A., Tropsha A., Predictive qsar modeling diversity sampling of experimental data set and test set selection. J. Comput. Aided Mol. Des. 2002, 5, 231-243.
16. Beebe, K.R.; Pell, R.J.; Seasholtz, M.B. Chemometrics, a Practical Guide; Wiley Interscience: New York, NY, USA, 1998.
17. Li, H.; Sun, J.; Sui, X.; Liu, J.; Yan, Z.; Liu, X.; Sun, Y.; He, Z. First-principle, structure-based prediction of hepatic metabolic clearance values in human. Eur. J. Med. Chem. 2009, 44, 1600-1606.
18. Vicini, P.; Geronikaki, A.; Incerti, M.; Zani, F.; Dearden, J.; Hewitt, M. 2-heteroarylimino-5- benzylidene-4-thiazolidinones analogues of 2-thiazolylimino-5-benzylidene-4-thiazolidinones with antimicrobial activity: Synthesis and structure-activity relationship. Bioorg. Med. Chem. 2008, 16, 3714-3724.
19. Korhonen S.M., A fuzzy superposition and qsar technique towards an automated computational detection of biologically active compounds using multivariate methods. PhD Thesis, University of Kuopio, Kuopio, Finland, 2007.
20. Lin, B.; Pirrung, M.C.; Deng, L.; Li, Z.; Liu, Y.; Webster, N.J.G. Neuroprotection by small molecule activators of the nerve growth factor receptor. J. Pharmacol. Exp. Ther. 2007, 322, 59-69.
21. 2! J. Mol. Graph. Model. 2002, 20, 269-276.
22. Windows Reference Guide, TSAR version 3.3; Oxford Molecular, Ltd.: Oxford, UK, 2000.
23. Banfi, S.; Caruso, E.; Buccafurni, L.; Murano, R.; Monti, E.; Gariboldi, M.; Papa, E.; Gramatica, P. Comparison between 5,10,15,20-tetraaryl- and diarylporphyrins as photosensitizers: Synthesis, photodynamic activity and quantitative structure activity relationship modeling. J. Med. Chem 2006, 49, 3293-3304.
24. Banfi, S., Caruso, E., Caprioli, S., Mazzagatti, L., Canti, G., Ravizza, R., Gariboldi, M., Monti, E., Photodynamic effects of porphyrin and chlorin photosensitizers in human colon adenocarcinoma cells. Bioorg. Med. Chem. 2004, 14, 4853-4860.
25. ChemDraw, version 6.0; Cambridge Scientific Computing, Inc.: Cambridge, MA, USA, 2004.
26. TSAR, version 3.3; Oxford Molecular, Ltd.: Oxford, UK, 2000.
27. Kamarulzaman, F.A.; Shaari, K.; Ho, A.S.H.; Lajis, N.H.; Teo, S.H.; Lee, H.B. Derivatives of pheophorbide-a and pheophorbide-b from photocytotoxic piper penangense extract. Chem. Biodivers. 2011, 8, 494-502.
28. Tan, P.J.; Appleton, D.R.; Mustafa, M.R.; Lee, H.B. Rapid identification of cyclic tetrapyrrolic photosensitisers for photodynamic therapy using on-line hyphenated lc-pda-ms coupled with photocytotoxicity assay. Phytochem. Anal. 2011, doi:10.1002/pca.1324.
29. Harris, P.G.; Pearce, G.E.S.; Peakman, T.M.; Maxwell, J.R. A widespread and abundant chlorophyll transformation product in aquatic environments. Org. Geochem. 1995, 23, 183-187.
30. Demberelnyamba, D.; Ariuna, M.; Shim, Y.K. Newly synthesized water-soluble cholinium-purpurin photosensitizers and their stabilized gold nanoparticle as promising anticancer agents. Int. J. Mol. Sci. 2008, 9, 864-871.
31. Ocampo, R.; Repeta, D.J. Structural determination of purpurin-18 (as methyl ester) from sedimentary organic matter. Org. Geochem. 1999, 30, 189-193.
32. Wongsinkongman, P.; Brossi, A.; Wang, H.K.; Bastow, K.F.; Lee, K.H. Antitumor agents. Part 209: Pheophorbide-a derivatives as photoindependent cytotoxic agents. Bioorg. Med. Chem. 2002, 10, 583-591.